Voyager Therapeutics Inc. (VYGR)
undefined
undefined%
At close: undefined

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13
PE Ratio 2.74 -5.04 -1.55 7.23 -12.26 -3.41 -6.29 -8.02 -3.09 -16.01 -1.07
PS Ratio 1.45 5.72 2.73 1.55 4.80 39.56 43.90 22.67 5.30 n/a n/a
PB Ratio 1.54 3.96 1.07 1.72 5.03 6.49 3.32 2.37 0.54 227.29 -2.14
P/FCF Ratio 4.86 -15.6 -1.85 -2.44 12.23 -14.93 -6.81 -6.78 2.28 -17.52 -1.51
P/OCF Ratio 4.66 -18.7 -1.91 -2.75 10.29 -18.97 -7.25 -7.59 2.22 -21.91 -1.51
OCF/S Ratio 0.31 -0.31 -1.43 -0.57 0.47 -2.09 -6.05 -2.99 2.38 n/a n/a
Debt / Equity Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.49 -0.76
Quick Ratio 4.96 1.70 2.65 7.13 3.98 4.97 10.69 12.84 9.41 3.38 0.03
Current Ratio 4.96 1.72 2.68 7.39 4.01 5.13 10.81 12.95 8.19 3.38 0.03
Asset Turnover 0.71 0.26 0.19 0.65 0.29 0.04 0.05 0.08 0.08 n/a n/a
Interest Coverage n/a -28.37 n/a n/a n/a n/a n/a -42.31 -61.01 n/a n/a
Return on Equity (ROE) 0.56 -0.79 -0.69 0.24 -0.41 -1.9 -0.53 -0.3 -0.18 -14.2 2.00
Return on Assets (ROA) 0.38 -0.29 -0.34 0.14 -0.12 -0.5 -0.38 -0.21 -0.13 -1.42 -51.45
Return on Capital (ROIC) 0.43 -0.59 -0.52 0.12 -0.19 -0.63 -0.43 -0.23 -0.1 -1.59 1.97
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 98.22% 84.87% -97.21% 36.45% -14.7% -751.88% -514.31% -197.11% -59.68% n/a n/a
Net Profit Margin 52.93% -113.45% -176.49% 21.47% -39.11% -1.16K% -697.56% -282.65% -171.18% n/a n/a
Pretax Profit Margin 53.49% -113.41% -190.29% 21.47% -41.76% -1.16K% -697.56% -282.29% -171.18% n/a n/a
Operating Profit Margin 48.80% -124.27% -196.76% 16.00% -49.51% -1.20K% -709.06% -290.43% -116.85% n/a n/a
FCF Margin 29.86% -36.67% -147.36% -63.59% 39.23% -265.02% -644.65% -334.11% 232.31% n/a n/a
EBITDA Margin 50.58% -109.14% -182.96% 18.23% -46.86% -1.17K% -693.32% -286.13% -113.38% n/a n/a